Dieulafoy’s Lesion of the Esophagus Correctly Diagnosed and Successfully Treated by the Endoscopic Injection of N-Butyl-2-Cyanoacrylate

Dieulafoy’s lesion is an arterial malformation in the subumucosal layer of the gastrointestinal tract that can cause massive bleeding. The esophagus is not a common location for this lesion. We present here a first report of Dieulafoy’s lesion of the esophagus correctly diagnosed and successfully treated by the endoscopic injection of N-butyl-2-cyanoacrylate.

References

• 1 Dieulafoy G. Exulceratio simplex.  Bull Acad Med. 1898;  39 49-84
• 2 Juler G L, Labitzke H G, Lamb R, Allen R. The pathogenesis of Dieulafoy’s gastric erosion.  Am J Gastroenterol. 1984;  79 195-200
• 3 Ikeda Y, Tamakawa R, Hatakeyama H. et al . Evaluation of endoscopic local injection of hypertonic saline-epinephrine solution and surgical treatment on hemorrhagic gastroduodenal ulcer.  Nippon Geka Gakkai Zasshi. 1989;  90 1545-1547 [In Japanese]
• 4 Kasapidis P, Georgopoulos P, Delis V, Balatsos V. et al . Endoscopic management and long-term follow-up of Dieulafoy’s lesions in the upper GI tract.  Gastrointest Endosc. 2002;  55 527-531
• 5 Ertekin C, Barbaros U, Taviloglu K. et al . Dieulafoy’s lesion of esophagus.  Surg Endosc. 2002;  16 219
• 6 Iso Y, Kawanaka H, Tomikawa M. et al . Repeated injection sclerotherapy is preferable to combined therapy with variceal ligation to avoid recurrence of esophageal varices: a prospective randomized trial.  Hepatogastroenterology. 1997;  44 467-471
• 7 Soehendra N, Grimm H, Nam V C. et al . N-butyl-2-cyanoacrylate: a supplement to endoscopic sclerotherapy.  Endoscopy. 1987;  19 221-224
• 8 Sheikh R A, Trudeau W L. Clinical evaluation of endoscopic injection sclerotherapy using N-butyl-2-cyanoacrylate for gastric variceal bleeding.  Gastrointest Endosc. 2000;  52 142-144